Herein, we present a protocol focusing on the quality control of the left anterior descending coronary artery ligation by technically modifying the traditional procedure in rats for acute myocardial ischemia-reperfusion research.
Coronary heart disease is the leading cause of death globally. Complete cessation of blood flow in coronary arteries causes ST-segment elevation myocardial infarction (STEMI), resulting in cardiogenic shock and fatal arrhythmia, which are associated with high mortality. Primary coronary intervention (PCI) for recanalizing the coronary artery significantly improves the outcomes of STEMI, but advancements made in shortening the door-to-balloon time have failed to reduce in-hospital mortality, suggesting that additional therapeutic strategies are required. Left anterior descending coronary artery (LAD) ligation in rats is an animal model for acute myocardial IR research that is comparable to the clinical scenario in which rapid coronary recanalization through PCI is used for STEMI; however, PCI-induced STEMI is a technically challenging and complicated operation associated with high mortality and great variation in infarction size. We identified the ideal position for LAD ligation, created a gadget to control a snare loop, and supported a modified surgical maneuver, thereby reducing tissue damage, to establish a reliable and reproducible acute myocardial ischemia-reperfusion (IR) research protocol for rats. This is a non-survival surgery. We also propose a method for validating the quality of study results, which is a critical step for determining the accuracy of subsequent biochemical analyses.
Ischemic heart disease is a leading cause of death worldwide1,2. In addition to the control of modifiable risk factors for preventing the development of coronary heart disease, therapeutic strategies are crucially required for acute coronary syndrome3,4. Cardiogenic shock and fatal arrhythmia in acute ST-segment elevation myocardial infarction (STEMI) have been found to increase the likelihood of in-hospital mortality5,6,7,8. Primary percutaneous coronary intervention (PCI) is the preferred treatment for STEMI9,10,11; however, the therapeutic effects have a ceiling when the door-to-balloon time is <90 min12,13. Additional strategies are required for further improving the clinical outcomes of the disease14,15,16,17,18,19.
An acute myocardial ischemia- reperfusion (IR) experiment involving left anterior descending artery (LAD) ligation in rats is one of the animal models comparable to the clinical scenario wherein short door-to-balloon times are required for patients with STEMI to rescue the heart from ischemic damage. However, surgery-induced STEMI in small animals is often technically challenging because it is a complex operation associated with high mortality and high variation in infarction size20,21,22,23,24. To overcome the technical challenge, the present study developed a comprehensive and effective animal model in rats (because they are larger than mice) to establish a reliable and reproducible acute myocardial IR research protocol through technical modification. The proposed protocol results in fewer surgical complications, less tissue damage, and less likelihood of mortality during surgery. Additionally, a procedure was used to measure the infarct size and area at risk (AAR) and, thus, verify the quality of the study results. The proposed protocol can be used to investigate the pathophysiological processes of acute myocardial IR stress to develop new therapeutic strategies against the damage.
All animal experiments were conducted in accordance with the Guide for the Care and Use of Laboratory Animals, published by the US National Institutes of Health (NIH publication no. 85-23, revised 1996). The study protocol was approved by and in accordance with the guidelines of the Institutional Animal Care and Use Committee at Fu-Jen Catholic University.
1. Preparation before surgery
2. LAD ligation
At the end of myocardial ischemia and reperfusion, the quality of LAD ligation should be assessed before further biochemical or molecular analyses.
The sufficiency of LAD occlusion through ligation was determined by injecting 1 mL of 2% Evan's blue dye through the central venous catheter. Then, the myocardium with coronary perfusion was stained blue compared with the non-perfused region, which remained red (Figure 1A). The red region is the AAR of myocardial infarction.
The accuracy of the location for LAD ligation was further evaluated by quantifying the variation in AAR percentage among the study animals. After the heart was sliced horizontally, the AAR percentage was determined by dividing the AAR by the whole myocardial mass (Figure 1B). A low variation in AAR percentage among the study animals indicated accurate location of the LAD ligation.
The myocardial infarct size is the primary result in acute myocardial IR research. To quantify this parameter, the sliced heart sections were incubated in 1% 2,3,5-triphenyltetrazolium chloride (TTC) in normal saline at 37 °C for 30 min and then in 10% formaldehyde for 3 days. The infarct area was white. The infarct size percentage was calculated as the ratio of the infarct area to the AAR (Figure 2).
Figure 1: Validation of LAD ligation quality with Evan's blue. (A) The AAR for myocardial infarction was the non-perfused myocardial mass that remained red even after Evan's blue was injected, thereby confirming secure LAD ligation. (B) The AAR percentage was calculated by dividing the AAR (red area) by the whole myocardial mass (red and blue area); a low variation in AAR percentage among the study animals demonstrated accurate location of the LAD ligation. A smaller infarct size was demonstrated in drug-treated groups as compared to non-treated groups. AAR, area at risk; LAD, left anterior descending artery. Please click here to view a larger version of this figure.
Figure 2: Quantification of myocardial infarct size in TTC treatment. Infarct size was estimated as the ratio of the infarct area (white area) to the AAR (red area) in the LAD ligation group. AAR, area at risk; TTC, triphenyltetrazolium chloride. Please click here to view a larger version of this figure.
The proposed protocol has several distinctive features, such as identifying the exact position for LAD ligation, creating a gadget to control a snare loop in a single suture, and supporting a modified surgical maneuver to reduce tissue damage, thus enabling researchers to ligate the LAD accurately, securely, and consistently, as well as control the state of the snare loop instantly for acute myocardial IR research.
The location of LAD ligation influences the area and size of the myocardial infarction. Ligation is generally suggested at a certain distance on the proximal LAD27,28. Overlooking the variance in coronary artery branching patterns may increase the variability in myocardial infarction23,24. In this study, the LAD was ligated immediately distal to the 1st branch of the LMCA, thus preventing accidental ligation of the left circumflex artery or septal artery and leading to consistent infarct size and a lower likelihood of fatal arrhythmia29,30,31.
Secure LAD ligation is essential for LAD occlusion. Experts have recommended that the LAD should be ligated with tiedto create one to three knots or with a small piece of tubing to compress the coronary artery32,33,34,35,36. In this paper, we suggest a controllable gadget with a snare loop to ligate the LAD in a single suture; this approach enables secure LAD ligation and instant control of loop closure and release while preventing tissue laceration, bleeding, and breaking of the strength of the suture during repeat myocardial puncture, arterial ligation, and ligature release. The approach is, thus, useful for experimental and validation procedures in acute myocardial IR research.
Recognizing anatomical features and histological properties during surgery is helpful for reducing tissue damage and improving study replication. Regarding the opening of the thorax, scholars have suggested separating the pectoral and 3rd or 4th intercostal muscles by using scissors, a retractor, forceps, blunt tweezers, or stitches to pull aside the thoracic muscles and rib cage32,33,35,37,38. The present study suggests an incision along the skin tension lines (the connective tissue framework of the skin)39,40, cutting a single rib's cartilage, which contains avascular flexible connective tissue41, and hooking the thoracic muscle and rib cages to open the chest wall. This approach helps maintain tissue integrity and reduces the bleeding risk. Additionally, starting the approach by identifying reliable surface makers through touch means that the surgical procedure utilizing a skin incision is highly repeatable and consistent.
Confirming the quality of myocardial infarction induced by LAD ligation is a critical step before the investigation of pathophysiological changes in acute myocardial IR research. In the literature, the occurrence of myocardial infarction after LAD ligation is confirmed by observing sudden regional paleness of the myocardium28,33; an acute ST segment of electrocardiogram elevation from the baseline33; elevated serum cardiac enzyme levels such as CK-MB, troponin I, and troponin T28,32,42; or infarcted regions macroscopically42. The consistency of LAD ligation should further be validated by determining the AAR for infarction by using Phthalo or Evan's blue dye32,35,37,38. Low variability in AAR percentage among samples proves the consistency and quality of the procedure for acute myocardial IR research. Moreover, the infarct area can be distinguished from the AAR by demarcating myocardial infarction regions with TTC28,36. Evans blue/TTC double staining was previously employed to evaluate the quality of a myocardial IR study ex vivo37. Compared with the requirement in ex vivo evaluations that the isolated heart be perfused under the Langendorff apparatus, this study supports the animal protocol of in vivo evaluation in which the results are obtained, and the quality of the study is validated instantly and directly.
More importantly, the use of Evan's blue and TTC to define the infarct area to AAR precludes the use of the infarcted myocardium for biochemical analyses, which is a requirement to exclude confounding factors and obtain accurate results in acute myocardial IR research.
The authors have nothing to disclose.
This model was developed with financial support from the Ministry of Science and Technology, Taiwan (MOST 109-2320-B-030-006-MY3).
Evan’s blue | Sigma Aldrich | E2129 | |
Forceps | Shinva | ||
Pentobarbital | Sigma Aldrich | 1507002 | |
Scalpel blades | Shinva | s2646 | |
Scalpel handles | Shinva | ||
Silk sutures | SharpointTM | DC-2150N | |
Surgical needle | AnchorTM | ||
Triphenyltetrazolium chloride (TTC) solution | Solarbio | T8170-1 | |
Ventilator | Harvard Rodent Ventilator |